Is Endoscopic Submucosal Dissection for Colorectal Lesions Performed in the Endoscopy Suite Safe and Cost Saving?

Cihad Tatar; Ilker Ozgur; Carla F Justiniano; Amit Bhatt; David Liska; Tracy Hull; Scott R Steele; Emre Gorgun

doi:10.1097/SLE.0000000000001118

Is Endoscopic Submucosal Dissection for Colorectal Lesions Performed in the Endoscopy Suite Safe and Cost Saving?

Surg Laparosc Endosc Percutan Tech. 2022 Dec 1;32(6):688-691. doi: 10.1097/SLE.0000000000001118.

Authors

Cihad Tatar¹, Ilker Ozgur¹, Carla F Justiniano¹, Amit Bhatt², David Liska¹, Tracy Hull¹, Scott R Steele¹, Emre Gorgun¹

Affiliations

¹ Department of Colorectal Surgery.
² Department of Gastroenterology and Hepatology, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, OH.

PMID: 36468893
DOI: 10.1097/SLE.0000000000001118

Abstract

Background: We aimed to compare the outcomes and the cost differences of endoscopic submucosal dissection (ESD) procedures in the endoscopy suite (ES) versus the operating room (OR).

Materials and methods: The procedures in the OR were compared with procedures performed in the ES for demographics, lesion characteristics, procedure outcome, and procedure charges. The study included 163 procedures in the ES and 73 in the OR.

Results: Both were similar in age, sex, body mass index, and intraprocedural and postoperative 30-day (late) complications. ES cases had significantly greater polyp size, were more commonly right-sided polyps, and had shorter hospital stays, with similar en bloc and margin-negative resection rates. The overall cost ratio of ESD procedures in ES to OR was 0.47 ( P <0.001).

Conclusions: Colorectal ESD procedures performed in the ES have similar efficacy and safety as those in the OR. Procedures performed in the ES were associated with a shorter length of stay and significant periprocedural cost savings.

MeSH terms

Colorectal Neoplasms* / pathology
Colorectal Neoplasms* / surgery
Cost Savings
Endoscopic Mucosal Resection* / methods
Endoscopy
Humans
Treatment Outcome